The updated savings scheme will encompass several key products in AstraZeneca’s US inhaled respiratory medicines lineup, ...

AstraZeneca has a heritage in respiratory medicine, but has not produced any new products in the field for some time. Its existing asthma and COPD franchise is made up of Pulmicort (which earned $ ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

UK-based global pharma company AstraZeneca and US consumer products company Honeywell have ... “The work we are doing with AstraZeneca developing a respiratory inhaler, with a new near-zero ...

AstraZeneca's Maria Belvisi explores innovative approaches in respiratory medicine, from AI-driven trials to next-gen therapeutics. Following a successful visit to COP 28 in Dubai, AstraZeneca’s ...

respiratory and immunology; and vaccine and immune therapies. Though the sale of COVID-19 products has somewhat disrupted AstraZeneca's revenue growth in recent years, it has generally been strong.

(MENAFN- EIN Presswire) Janssen, Sanofi, AstraZeneca, Moderna, ReViral, and Pfizer are advancing Respiratory Syncytial Virus treatments to improve patient outcomes. LAS VEGAS , NV, UNITED STATES ...